Lifeline Biotechnologies Inc (LLBO)

[SquirrelCage]

Hey, Bro -

I understand your point. But the video with Rob did clearly say that the launch into the Hong Kong market was first going to be through physician offices until all the regulatory hurdles were cleared. So, depending on if you want to interpret launch to mean "availability" or only "over the counter to the masses" is the issue. Part 2 of the HKIBC interview - around minute 6 or 7 - says that launching through the doctors first will accelerate the public release in late '19 or early '20. That would be like the current FDA clearance here in the U.S. which allows iTbra use through physicians only. Although the U.S. trials were very specific to women already diagnosed by mammogram, I don't know that Hong Kong will be limited that way. After doctors are able to verify and convey positive results, we're still on track with "a launch"... unless January passes without news confirming it.